|
?:authorAffiliation
|
-
[\'Texas A&M School of Public Health, College Station, TX, USA; Hagler Institute for Advanced Study at Texas A&M University, College Station, TX, USA.\', \'Department of Health and Kinesiology, Texas A&M University, College Station, TX, USA; Laboratory for Community Health Evaluation and Systems Science (CHESS), Texas A&M University, College Station, TX, USA.\', \'Texas A&M School of Public Health, College Station, TX, USA.\', \'Hagler Institute for Advanced Study at Texas A&M University, College Station, TX, USA; Texas Children\'s Hospital Center for Vaccine Development and Center for Medical Ethics and Health Policy, Departments of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Scowcroft Institute of International Affairs, Bush School of Policy and Government, Texas A&M University, College Station, TX, USA; Department of Biology, Baylor University, Waco, TX, USA; James A Baker III Institute of Public Policy, Rice University Houston, TX, USA.\', \'Texas A&M School of Public Health, College Station, TX, USA; School of Nursing and Health Professions, University of San Francisco, San Francisco, CA, USA; UCLA Fielding School of Public Health, Los Angeles, CA, USA. Electronic address: akregan@usfca.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}